Benjamin M Smith1,2, Miranda Kirby3, Eric A Hoffman4,5,6, Richard A Kronmal7, Shawn D Aaron8, Norrina B Allen9, Alain Bertoni10, Harvey O Coxson11, Chris Cooper12, David J Couper13, Gerard Criner14, Mark T Dransfield15, MeiLan K Han16, Nadia N Hansel17, David R Jacobs18, Joel D Kaufman19,20, Ching-Long Lin21, Ani Manichaikul22, Fernando J Martinez23, Erin D Michos17, Elizabeth C Oelsner1, Robert Paine24, Karol E Watson12, Andrea Benedetti2, Wan C Tan25, Jean Bourbeau2, Prescott G Woodruff26, R Graham Barr1. 1. Department of Medicine, Columbia University Medical Center, New York, New York. 2. Department of Medicine, McGill University, Montreal, Quebec, Canada. 3. Department of Physics, Ryerson University, Toronto, Ontario, Canada. 4. Department of Radiology, University of Iowa, Iowa City. 5. Department of Biomedical Engineering, University of Iowa, Iowa City. 6. Department of Internal Medicine, University of Iowa, Iowa City. 7. Department of Biostatistics, University of Washington, Seattle. 8. Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. 9. Department of Medicine, Northwestern University, Chicago, Illinois. 10. Department of Medicine, Wake Forest University, Winston-Salem, North Carolina. 11. Department of Radiology, University of British Columbia, Vancouver, Canada. 12. Department of Medicine, University of California, Los Angeles. 13. Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill. 14. Department of Medicine, Temple University, Philadelphia, Pennsylvania. 15. Department of Medicine, University of Alabama at Birmingham, Birmingham. 16. Department of Medicine, University of Michigan, Ann Arbor. 17. Department of Medicine, Johns Hopkins University, Baltimore, Maryland. 18. Division of Epidemiology and Community Health School of Public Health, University of Minnesota, Minneapolis. 19. Department of Epidemiology, University of Washington, Seattle. 20. Department of Environmental and Occupational Health Sciences, University of Washington, Seattle. 21. Department of Mechanical Engineering, University of Iowa, Iowa City. 22. Department of Public Health Sciences, University of Virginia, Charlottesville. 23. Department of Medicine, Cornell University, New York, New York. 24. Department of Medicine, University of Utah, Salt Lake City. 25. Department of Medicine, University of British Columbia, Vancouver, Canada. 26. Department of Medicine, University of California, San Francisco.
Abstract
Importance: Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), yet much of COPD risk remains unexplained. Objective: To determine whether dysanapsis, a mismatch of airway tree caliber to lung size, assessed by computed tomography (CT), is associated with incident COPD among older adults and lung function decline in COPD. Design, Setting, and Participants: A retrospective cohort study of 2 community-based samples: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study, which involved 2531 participants (6 US sites, 2010-2018) and the Canadian Cohort of Obstructive Lung Disease (CanCOLD), which involved 1272 participants (9 Canadian sites, 2010-2018), and a case-control study of COPD: the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS), which involved 2726 participants (12 US sites, 2011-2016). Exposures: Dysanapsis was quantified on CT as the geometric mean of airway lumen diameters measured at 19 standard anatomic locations divided by the cube root of lung volume (airway to lung ratio). Main Outcomes and Measures: Primary outcome was COPD defined by postbronchodilator ratio of forced expired volume in the first second to vital capacity (FEV1:FVC) less than 0.70 with respiratory symptoms. Secondary outcome was longitudinal lung function. All analyses were adjusted for demographics and standard COPD risk factors (primary and secondhand tobacco smoke exposures, occupational and environmental pollutants, and asthma). Results: In the MESA Lung sample (mean [SD] age, 69 years [9 years]; 1334 women [52.7%]), 237 of 2531 participants (9.4%) had prevalent COPD, the mean (SD) airway to lung ratio was 0.033 (0.004), and the mean (SD) FEV1 decline was -33 mL/y (31 mL/y). Of 2294 MESA Lung participants without prevalent COPD, 98 (4.3%) had incident COPD at a median of 6.2 years. Compared with participants in the highest quartile of airway to lung ratio, those in the lowest had a significantly higher COPD incidence (9.8 vs 1.2 cases per 1000 person-years; rate ratio [RR], 8.12; 95% CI, 3.81 to 17.27; rate difference, 8.6 cases per 1000 person-years; 95% CI, 7.1 to 9.2; P < .001) but no significant difference in FEV1 decline (-31 vs -33 mL/y; difference, 2 mL/y; 95% CI, -2 to 5; P = .30). Among CanCOLD participants (mean [SD] age, 67 years [10 years]; 564 women [44.3%]), 113 of 752 (15.0%) had incident COPD at a median of 3.1 years and the mean (SD) FEV1 decline was -36 mL/y (75 mL/y). The COPD incidence in the lowest airway to lung quartile was significantly higher than in the highest quartile (80.6 vs 24.2 cases per 1000 person-years; RR, 3.33; 95% CI, 1.89 to 5.85; rate difference, 56.4 cases per 1000 person-years; 95% CI, 38.0 to 66.8; P<.001), but the FEV1 decline did not differ significantly (-34 vs -36 mL/y; difference, 1 mL/y; 95% CI, -15 to 16; P=.97). Among 1206 SPIROMICS participants (mean [SD] age, 65 years [8 years]; 542 women [44.9%]) with COPD who were followed up for a median 2.1 years, those in the lowest airway to lung ratio quartile had a mean FEV1 decline of -37 mL/y (15 mL/y), which did not differ significantly from the decline in MESA Lung participants (P = .98), whereas those in highest quartile had significantly faster decline than participants in MESA Lung (-55 mL/y [16 mL/y ]; difference, -17 mL/y; 95% CI, -32 to -3; P = .004). Conclusions and Relevance: Among older adults, dysanapsis was significantly associated with COPD, with lower airway tree caliber relative to lung size associated with greater COPD risk. Dysanapsis appears to be a risk factor associated with COPD.
Importance: Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), yet much of COPD risk remains unexplained. Objective: To determine whether dysanapsis, a mismatch of airway tree caliber to lung size, assessed by computed tomography (CT), is associated with incident COPD among older adults and lung function decline in COPD. Design, Setting, and Participants: A retrospective cohort study of 2 community-based samples: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study, which involved 2531 participants (6 US sites, 2010-2018) and the Canadian Cohort of Obstructive Lung Disease (CanCOLD), which involved 1272 participants (9 Canadian sites, 2010-2018), and a case-control study of COPD: the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS), which involved 2726 participants (12 US sites, 2011-2016). Exposures: Dysanapsis was quantified on CT as the geometric mean of airway lumen diameters measured at 19 standard anatomic locations divided by the cube root of lung volume (airway to lung ratio). Main Outcomes and Measures: Primary outcome was COPD defined by postbronchodilator ratio of forced expired volume in the first second to vital capacity (FEV1:FVC) less than 0.70 with respiratory symptoms. Secondary outcome was longitudinal lung function. All analyses were adjusted for demographics and standard COPD risk factors (primary and secondhand tobacco smoke exposures, occupational and environmental pollutants, and asthma). Results: In the MESA Lung sample (mean [SD] age, 69 years [9 years]; 1334 women [52.7%]), 237 of 2531 participants (9.4%) had prevalent COPD, the mean (SD) airway to lung ratio was 0.033 (0.004), and the mean (SD) FEV1 decline was -33 mL/y (31 mL/y). Of 2294 MESA Lung participants without prevalent COPD, 98 (4.3%) had incident COPD at a median of 6.2 years. Compared with participants in the highest quartile of airway to lung ratio, those in the lowest had a significantly higher COPD incidence (9.8 vs 1.2 cases per 1000 person-years; rate ratio [RR], 8.12; 95% CI, 3.81 to 17.27; rate difference, 8.6 cases per 1000 person-years; 95% CI, 7.1 to 9.2; P < .001) but no significant difference in FEV1 decline (-31 vs -33 mL/y; difference, 2 mL/y; 95% CI, -2 to 5; P = .30). Among CanCOLD participants (mean [SD] age, 67 years [10 years]; 564 women [44.3%]), 113 of 752 (15.0%) had incident COPD at a median of 3.1 years and the mean (SD) FEV1 decline was -36 mL/y (75 mL/y). The COPD incidence in the lowest airway to lung quartile was significantly higher than in the highest quartile (80.6 vs 24.2 cases per 1000 person-years; RR, 3.33; 95% CI, 1.89 to 5.85; rate difference, 56.4 cases per 1000 person-years; 95% CI, 38.0 to 66.8; P<.001), but the FEV1 decline did not differ significantly (-34 vs -36 mL/y; difference, 1 mL/y; 95% CI, -15 to 16; P=.97). Among 1206 SPIROMICS participants (mean [SD] age, 65 years [8 years]; 542 women [44.9%]) with COPD who were followed up for a median 2.1 years, those in the lowest airway to lung ratio quartile had a mean FEV1 decline of -37 mL/y (15 mL/y), which did not differ significantly from the decline in MESA Lung participants (P = .98), whereas those in highest quartile had significantly faster decline than participants in MESA Lung (-55 mL/y [16 mL/y ]; difference, -17 mL/y; 95% CI, -32 to -3; P = .004). Conclusions and Relevance: Among older adults, dysanapsis was significantly associated with COPD, with lower airway tree caliber relative to lung size associated with greater COPD risk. Dysanapsis appears to be a risk factor associated with COPD.
Authors: Ali H Mokdad; Katherine Ballestros; Michelle Echko; Scott Glenn; Helen E Olsen; Erin Mullany; Alex Lee; Abdur Rahman Khan; Alireza Ahmadi; Alize J Ferrari; Amir Kasaeian; Andrea Werdecker; Austin Carter; Ben Zipkin; Benn Sartorius; Berrin Serdar; Bryan L Sykes; Chris Troeger; Christina Fitzmaurice; Colin D Rehm; Damian Santomauro; Daniel Kim; Danny Colombara; David C Schwebel; Derrick Tsoi; Dhaval Kolte; Elaine Nsoesie; Emma Nichols; Eyal Oren; Fiona J Charlson; George C Patton; Gregory A Roth; H Dean Hosgood; Harvey A Whiteford; Hmwe Kyu; Holly E Erskine; Hsiang Huang; Ira Martopullo; Jasvinder A Singh; Jean B Nachega; Juan R Sanabria; Kaja Abbas; Kanyin Ong; Karen Tabb; Kristopher J Krohn; Leslie Cornaby; Louisa Degenhardt; Mark Moses; Maryam Farvid; Max Griswold; Michael Criqui; Michelle Bell; Minh Nguyen; Mitch Wallin; Mojde Mirarefin; Mostafa Qorbani; Mustafa Younis; Nancy Fullman; Patrick Liu; Paul Briant; Philimon Gona; Rasmus Havmoller; Ricky Leung; Ruth Kimokoti; Shahrzad Bazargan-Hejazi; Simon I Hay; Simon Yadgir; Stan Biryukov; Stein Emil Vollset; Tahiya Alam; Tahvi Frank; Talha Farid; Ted Miller; Theo Vos; Till Bärnighausen; Tsegaye Telwelde Gebrehiwot; Yuichiro Yano; Ziyad Al-Aly; Alem Mehari; Alexis Handal; Amit Kandel; Ben Anderson; Brian Biroscak; Dariush Mozaffarian; E Ray Dorsey; Eric L Ding; Eun-Kee Park; Gregory Wagner; Guoqing Hu; Honglei Chen; Jacob E Sunshine; Jagdish Khubchandani; Janet Leasher; Janni Leung; Joshua Salomon; Jurgen Unutzer; Leah Cahill; Leslie Cooper; Masako Horino; Michael Brauer; Nicholas Breitborde; Peter Hotez; Roman Topor-Madry; Samir Soneji; Saverio Stranges; Spencer James; Stephen Amrock; Sudha Jayaraman; Tejas Patel; Tomi Akinyemiju; Vegard Skirbekk; Yohannes Kinfu; Zulfiqar Bhutta; Jost B Jonas; Christopher J L Murray Journal: JAMA Date: 2018-04-10 Impact factor: 56.272
Authors: Marie Ng; Michael K Freeman; Thomas D Fleming; Margaret Robinson; Laura Dwyer-Lindgren; Blake Thomson; Alexandra Wollum; Ella Sanman; Sarah Wulf; Alan D Lopez; Christopher J L Murray; Emmanuela Gakidou Journal: JAMA Date: 2014-01-08 Impact factor: 56.272
Authors: A William Sheel; Jordan A Guenette; Ren Yuan; Lukas Holy; John R Mayo; Annette M McWilliams; Stephen Lam; Harvey O Coxson Journal: J Appl Physiol (1985) Date: 2009-09-17
Authors: Miranda Kirby; Naoya Tanabe; Wan C Tan; Guohai Zhou; Ma'en Obeidat; Cameron J Hague; Jonathon Leipsic; Jean Bourbeau; Don D Sin; James C Hogg; Harvey O Coxson Journal: Am J Respir Crit Care Med Date: 2018-01-01 Impact factor: 21.405
Authors: Benjamin M Smith; Hussein Traboulsi; John H M Austin; Ani Manichaikul; Eric A Hoffman; Eugene R Bleecker; Wellington V Cardoso; Christopher Cooper; David J Couper; Stephen M Dashnaw; Jia Guo; MeiLan K Han; Nadia N Hansel; Emlyn W Hughes; David R Jacobs; Richard E Kanner; Joel D Kaufman; Eric Kleerup; Ching-Long Lin; Kiang Liu; Christian M Lo Cascio; Fernando J Martinez; Jennifer N Nguyen; Martin R Prince; Stephen Rennard; Stephen S Rich; Leora Simon; Yanping Sun; Karol E Watson; Prescott G Woodruff; Carolyn J Baglole; R Graham Barr Journal: Proc Natl Acad Sci U S A Date: 2018-01-16 Impact factor: 11.205
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Wilson D Pace; Elias Brandt; Victoria A Carter; Ku-Lang Chang; Chelsea L Edwards; Alexander Evans; Chester Fox; Gabriela Gaona; MeiLan K Han; Alan G Kaplan; Rachel Kent; Janwillem W H Kocks; Maja Kruszyk; Chantal E Le Lievre; Tessa Li Voti; Cathy Mahle; Barry Make; Amanda R Ratigan; Asif Shaikh; Neil Skolnik; Brooklyn Stanley; Barbara P Yawn; David B Price Journal: Ann Fam Med Date: 2022 Jul-Aug Impact factor: 5.707
Authors: Xuan Zhang; Frank Li; Prathish K Rajaraman; Jiwoong Choi; Alejandro P Comellas; Eric A Hoffman; Benjamin M Smith; Ching-Long Lin Journal: Eur J Pharm Sci Date: 2022-07-29 Impact factor: 5.112
Authors: Motahareh Vameghestahbanati; Grant T Hiura; R Graham Barr; Jessica C Sieren; Benjamin M Smith; Eric A Hoffman Journal: Chest Date: 2021-08-12 Impact factor: 10.262
Authors: Seyram Kaali; Darby W Jack; Rebecca K D Prah; Steven N Chillrud; Mohammed N Mujtaba; Patrick L Kinney; Theresa Tawiah; Qiang Yang; Felix B Oppong; Carlos F Gould; Musah Osei; Blair J Wylie; Oscar Agyei; Matthew S Perzanowski; Kwaku Poku Asante; Alison G Lee Journal: Pediatr Pulmonol Date: 2022-06-13
Authors: Surya P Bhatt; Sandeep Bodduluri; Abhilash S Kizhakke Puliyakote; Elizabeth C Oelsner; Arie Nakhmani; David A Lynch; Carla G Wilson; Spyridon Fortis; Victor Kim Journal: Thorax Date: 2021-01-06 Impact factor: 9.139
Authors: Motahareh Vameghestahbanati; Miranda Kirby; Naoya Tanabe; Dragoş M Vasilescu; Wim Janssens; Stephanie Everaerts; Bart M Vanaudenaerde; Andrea Benedetti; James C Hogg; Benjamin M Smith Journal: Am J Respir Crit Care Med Date: 2021-02-01 Impact factor: 21.405
Authors: Motahareh Vameghestahbanati; Miranda Kirby; François Maltais; Dennis Jensen; Dany Doiron; Wan C Tan; Jean Bourbeau; Benjamin M Smith Journal: Am J Respir Crit Care Med Date: 2021-10-15 Impact factor: 30.528